Arizona Revised Statutes §13-3401
Arizona controlled-substance definitions and schedules.
Open sourceNo. Psilocybin mushrooms are illegal statewide in Arizona in 2026; university research funding does not create public access.
HB 2759 (2024) appropriated $5M for psilocybin research at Arizona universities; separate ibogaine interest via veterans-focused legislation.
Arizona has the most active psilocybin legislative history of any state without a consumer program. HB 2759 (2024) appropriated $5M for university research. SB 1570 (2024) would have created Oregon-style service centers; it passed both chambers but was vetoed by Gov. Hobbs in July 2024. SB 1555 (2025) was signed into law on April 22, 2025 (Chapter 231) as a conditional trigger law: pharmaceutical crystalline polymorph psilocybin may be prescribed in Arizona if the FDA approves it and the DEA reschedules it out of Schedule I by January 1, 2031. A state Psilocybin Advisory Board was established and held its first meeting in early 2026. Psilocybin mushrooms remain Schedule I under Arizona Revised Statutes §13-3401; no decriminalization or licensed access program exists today.
Arizona controlled-substance definitions and schedules.
Open sourceOfficial source for Arizona psilocybin research and therapeutic-access bills.
Open sourceAs of 2026, Arizona does not have a licensed psilocybin access program. Legal options for residents include:
Get notified when Arizona's psychedelic laws change
Bills, votes, and effective dates — delivered when they happen.
No. Psilocybin mushrooms are illegal statewide in Arizona in 2026; university research funding does not create public access.
No. Psilocybin remains Schedule I under Arizona Revised Statutes §13-3401. SB 1555 (signed April 2025) created a conditional framework allowing prescription of FDA-approved psilocybin if it is also rescheduled by DEA by 2031 — but no licensed program or decriminalization exists today.
No. Psilocybin remains a Schedule I controlled substance under Arizona Revised Statutes §13-3401 for possession or use. SB 1555, signed by Gov. Hobbs on April 22, 2025 (Chapter 231), created a conditional framework: pharmaceutical crystalline polymorph psilocybin may be prescribed in Arizona only if the FDA approves it and the DEA reschedules it out of Schedule I by January 1, 2031. No licensed access program or decriminalization exists today.
No. Neither Phoenix, Scottsdale, Tempe, nor any other Arizona city has passed a decriminalization or deprioritization resolution for psilocybin mushrooms. Arizona state law (Schedule I) applies throughout the state.
Arizona has the most active psilocybin legislative record of any state without a consumer program. HB 2759 (2024) directed $5M to state universities for psilocybin research. SB 1570 (2024) would have established Oregon-style regulated service centers; it passed both chambers but was vetoed by Gov. Hobbs in July 2024. SB 1555 (2025) was then signed into law on April 22, 2025 (Chapter 231) as a conditional trigger law — pharmaceutical psilocybin may be prescribed if FDA approves it and DEA reschedules it by Jan 1, 2031. A Psilocybin Advisory Board was established and held its first meeting in early 2026.
No. Sedona is a popular destination for wellness retreats, but psilocybin remains Schedule I in Arizona. Retreat operators in the Sedona area who offer 'mushroom ceremonies' operate outside the law under both Arizona and federal law.
Suggest a tool, topic, or improvement that would make this site more useful.